Research ArticleProceedings of the 2017 Viral Clearance Symposium
Proceedings of the 2017 Viral Clearance Symposium, Session 6: Ensuring Viral Safety in Continuous Processing
Sarah A. Johnson and David Roush
PDA Journal of Pharmaceutical Science and Technology September 2018, 72 (5) 516-524; DOI: https://doi.org/10.5731/pdajpst.2018.009183
Sarah A. Johnson
1Center for Drug Evaluation and Research, Office of Biotechnology Products, U.S. Food and Drug Administration, Silver Spring, MD; and
David Roush
2Bioprocess Development/Biologics Research, Merck & Co., Inc., Kenilworth, NJ, USA
Reference
- 1.↵
- Chinniah S.,
- Hinckley P.,
- Connell-Crowley L.
- 2.↵
- Orozco R.,
- Godfrey S.,
- Coffman J.,
- Amarikwa L.,
- Parker S.,
- Hernandez L.,
- Wachuku C.,
- Mai B.,
- Song B.,
- Hoskatti S.,
- Asong J.,
- Shamlou P.,
- Bardliving C.,
- Fiadeiro M.
- 3.↵
- Parker S. A.,
- Amarikwa L.,
- Vehar K.,
- Orozco R.,
- Godfrey S.,
- Coffman J.,
- Shamlou P.,
- Bardliving C. L.
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 72, Issue 5
September/October 2018
Proceedings of the 2017 Viral Clearance Symposium, Session 6: Ensuring Viral Safety in Continuous Processing
Sarah A. Johnson, David Roush
PDA Journal of Pharmaceutical Science and Technology Sep 2018, 72 (5) 516-524; DOI: 10.5731/pdajpst.2018.009183
Jump to section
Related Articles
- No related articles found.